🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

France, Germany shares hit record highs, but give up gains after U.S CPI

Published 12/12/2023, 08:30
Updated 12/12/2023, 17:21
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, December 6, 2023. REUTERS/Staff/File Photo
NOKIA
-
STOXX
-

By Ankika Biswas, Khushi Singh and Bansari Mayur Kamdar

(Reuters) -France and Germany's benchmark stock indexes briefly touched record highs on Tuesday after data showed U.S. consumer prices unexpectedly rose last month, adding to nervousness in a week packed with interest rate decisions by major central banks.

The pan-European STOXX 600 slipped 0.2% by the close, as traders pulled back bets the Federal Reserve could start interest rate cuts as soon as March after the U.S. consumer prices report.

France's CAC-40 index eased 0.1% after rising as much as 0.4% and hitting an all-time high of 7,582.47 points intraday.

Germany's DAX gained as much as 0.3% and touched a record high of 16,837.18 points, before closing the session flat.

Also weighing on the market, British wage growth slowed by the most in almost two years, though pay is probably still rising too fast for the Bank of England to relax its stance against cutting interest rates.

"I'm expecting all the central banks to remind markets they could still hike if they want to," said Giles Coghlan, chief market analyst at brokerage GCFX.

"The last thing they want to do is to signal they've won the inflation battle prematurely, because that will just allow markets to run positive on risk."

Carl Zeiss Meditec jumped 6.5% after the medical technology firm reported higher annual revenue and a more optimistic forecast.

Italy's Banco BPM (LON:0RLA) rose 1.2% after pledging to moderately grow profits through 2026.

Novo Nordisk (CSE:NOVOb), the producer of blockbuster obesity drug Wegovy, fell 1.2% after a study showed patients regained weight after stopping rival Eli Lilly (NYSE:LLY)'s weight-loss drug.

AstraZeneca (NASDAQ:AZN) gained 0.8% on plans to buy U.S.-based vaccine developer Icosavax in a $1.1 billion deal.

Hargreaves Lansdown (LON:HRGV) fell 6.7% after Britain's market watchdog expressed concerns about the amount of interest and fees charged by some investment platforms.

BT Group (LON:BT) fell 3.9%, with traders linking the drop to British communications regulator Ofcom proposing a ban on mid-contract price hikes linked to inflation.

Telefonica (BME:TEF), which owns British telecom services provider O2 UK, was down 5.4%, as its shares traded ex-dividend in Madrid.

© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, December 6, 2023. REUTERS/Staff/File Photo

Hannover Re advanced 2.1% as the reinsurer said it expected a 24% surge in 2024 net profit over its current-year guidance.

Meanwhile, Warsaw's WIG 20 eased 0.9%, a day after Donald Tusk was appointed as the country's prime minister.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.